Answers are grounded in this paper and cite their sources.
Titanium and titanium alloys remain the dominant dental implant materials because of their strength, corrosion resistance and capacity for osseointegration. However, conventional titanium surfaces do not fully solve clinically relevant problems such as delayed integration in compromised bone, peri-implant infection, stress shielding, aesthetic grey shine-through, corrosion-assisted ion release and limited capacity for local drug delivery. Nanostructured titanium composites and nanocomposite coatings are therefore being developed to combine the mechanical reliability of titanium with nanoscale bioactivity, antibacterial function and controlled surface chemistry. This revised review addresses the specific gap left by earlier reviews: it classifies titanium-based nanocomposites by reinforcement chemistry and implant function, and connects nanoscale reinforcement size, morphology, dispersion and interfacial stability with mechanical, corrosion, osteogenic and antibacterial performance. Key aspects of ceramic, metallic, carbon-based, polymeric and bioactive and functionally graded (FG) titanium nanocomposites are critically analysed in terms of hydroxyapatite crystallinity, phase stability, coating adhesion as well as surface roughness, wettability, nano-topography and passive oxide-layer protection in oral environments. The quantitative findings of representative studies are summarized differentiating experimentally achieved performance gains from those proven clinically beneficial. It also reviewed the cytotoxicity and long-term risks of silver, nickel/cobalt, graphene derivatives, nanotubes and detached nanoparticles. While in vitro and animal studies support enhanced osteoblast response, corrosion protection and antibacterial activity, clinical evidence is thin, heterogeneous, and insufficient to confidently assert 3D-printed metal structures offer improved long-term implant survival - hydroxyapatite [HA]-coated or micro-rough titanium systems have well-established results. Next steps toward translation will require standardized assays, reproducible manufacturing, validated sterilization process and in vivo studies with proper power that would allow clinical trials.
No takes yet. Share an insight, caveat, or question.
Panda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: